What factors should I consider when comparing ICICI Pru MidCap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)?

When comparing ICICI Pru MidCap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G), consider factors such as historical performance, expense ratios, investment strategy, risk level, and the fund manager's credibility. Moreover, look at asset allocation and how each fund fits your investment goals.

Can I invest in ICICI Pru MidCap Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) simultaneously?

Yes, you can invest in both ICICI Pru MidCap Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) at the same time. This can help diversify your portfolio and balance risk, provided the fund manager's investment strategies streamline each other.

What does the portfolio turnover ratio tell us when comparing ICICI Pru MidCap Fund - Direct (G) and Nippon India Pharma Fund - Direct (G)?

While comparing ICICI Pru MidCap Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), the portfolio turnover ratio indicates how frequently assets within the fund are bought and sold. A high turnover may lead to higher transaction costs and tax implications, while a low turnover ratio indicates a buy-and-hold strategy.

Can I switch between ICICI Pru MidCap Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) if needed?

Yes, you can typically switch between ICICI Pru MidCap Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), subject to the fund's policies and any applicable fees. It is important to consider potential tax implications and the timing of your switch.

Can I compare ICICI Pru MidCap Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) based on their dividend payout?

Yes, you can compare ICICI Pru MidCap Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) based on their dividend payouts. Look at dividends profit, consistency, and growth, as these factors can influence your overall return on investment.

Compare ICICI Pru MidCap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G) Online

Home

Mutual Funds

Compare Mutual Funds

ICICI Pru MidCap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

ICICI Pru MidCap Fund - Direct (G)

13.25%

Nippon India Pharma Fund - Direct (G)

7.4%

Loading chart...

About Fund

Custodian

HDFC Bank Limited

Registrar

Computer Age Management Services Pvt. Ltd.

Custodian

Deutsche Bank AG

Registrar

Karvy Computershare Pvt. Ltd.

Fund Details

Risk

Very High Risk

Min SIP Amount

5000

Fund Size

7845.63

Expense Ratio

1.27

NAV

376.46

Launch Date

January 1, 2013

Exit Load

Risk

Very High Risk

Min SIP Amount

5000

Fund Size

9044.23

Expense Ratio

1.12

NAV

634.5023

Launch Date

January 1, 2013

Exit Load

Risk

Very High Risk

Min SIP Amount

5000

Fund Size

7845.63

Expense Ratio

1.27

NAV

376.46

Launch Date

January 1, 2013

Exit Load

Risk

Very High Risk

Min SIP Amount

5000

Fund Size

9044.23

Expense Ratio

1.12

NAV

634.5023

Launch Date

January 1, 2013

Exit Load

18.21 %

23.05 %

13.25 %

14.01 %

19.35 %

7.4 %

Fund Manager

Lalit Kumar

Qualification

Post Graduate diploma in Management (PGDM) - Indian Institute of Management, Calcutta (2010) and B.Tech in Electrical Engineering - Indian Institute of Technology, Kanpur (2006)

Experience

He joined ICICI Prudential Asset Management Company Limited in May 2017 as a Senior Manager. Past Experience: East Bridge Advisors Pvt. Ltd - Equity Research Analyst - July 2015 to April 2017. Nomura Financial Advisory & Securities - Equity Research - June 2010 to July 2015. Merrill Lynch - Intern - April 2009 to June 2009. Cypress Semiconductors - Senior Design Engineer - August 2006 to May 2008.

Fund Manager

Mrinal Singh

Qualification

BE (Mech), PGDM (SPJIMR - Mumbai)

Experience

He has an overall experience of around 16 years. He is associated with ICICI Prudential Asset Management Company Limited since June 2008. Past Experience: Wipro Ltd - IT Services - May 2005 to May 2008. BOSCH India (erstwhile MICO) - R&D - October 2000 to June 2003.

Fund Manager

Prakash Gaurav Goel

Qualification

Chartered Accountant and Bachelor or Commerce

Experience

Overall experience of 14 years in investment related activities. 2008-till September 20, 2017 - Vice President, Equity Research ICICI Securities Limited. 2006-2008-Research-Manager, IREVNA Research. 2003-2006-Commercial Manager, Hindustan Unilever.

Fund Manager

Sailesh Raj Bhan

Qualification

MBA (Finance), CFA.

Experience

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

ICICI Pru MidCap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

ICICI Pru MidCap Fund - Direct (G)

13.25%

Nippon India Pharma Fund - Direct (G)

7.4%

About Fund

Fund Details

Get your FAQs right